CMS Open Payments · Program Year 2024
DENTSPLY IH Inc.
DENTSPLY IH Inc. reported $389,935.86 across General Payments, Research, and Ownership to 1,122 physicians and teaching hospitals across 1,122 transactions.
- $389.9K
- All-tracks total
- 1,122
- Transactions
- 1,122
- Recipients
- +$96.9K
- General Payments vs PY2023
DENTSPLY IH Inc. reported $389,935.86 across all CMS Open Payments tracks (General + Research + Ownership) to 1,122 physicians and teaching hospitals in Program Year 2024 - ranking #833 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $389,935.86, averaging $347.54 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer dentsply-ih-inc DENTSPLY IH Inc.
$389.9K · #833/1,925 · 0.0% industry · PY2024
- TOT $389.9K
- RANK #833
- SHARE 0.0%
- TXN 1,122
- RCP 1,122
- CAT 6
- GEN $389.9K
- ΔGEN +$96.9K
- TOP1 12.8%
- PY 2024
Volume peers
Nearest volume peer: Mallinckrodt LLC ($390.2K)
DENTSPLY IH Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
DENTSPLY IH Inc.'s CMS-reported General Payments increased by $96.9K (+33.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: DENTSPLY IH INC.PY2023: DENTSPLY IH INC.PY2024: DENTSPLY IH Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $293,038.63
- PY2024
- $389,935.86
What the Data Shows for DENTSPLY IH Inc.
Averaging $347.54 per transaction and $347.54 per recipient, DENTSPLY IH Inc.'s Program Year 2024 total comes to $389,935.86 across 1,122 transactions and 1,122 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #833 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
"Compensation for Faculty or Speaker (Medical Education)" leads the 6-category general-payment breakdown below at $217.2K (55.7% of General Payments, 56 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
"Compensation for Faculty or Speaker (Medical Education)" leads DENTSPLY IH Inc.'s 6-category general-payment breakdown at $217.2K, 55.7% of the reported total.
DENTSPLY IH Inc. reports 6 general-payment categories - the top three are Compensation for Faculty or Speaker (Medical Education) (55.7%), Travel and Lodging (30.7%), and Food and Beverage (11.8%). The remaining 3 categories make up 1.9% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How DENTSPLY IH Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Faculty or Speaker (Medical Education) | $217.2K | 56 | 55.7% |
| Travel and Lodging | $119.5K | 356 | 30.7% |
| Food and Beverage | $45.9K | 661 | 11.8% |
| Consulting Fee | $3.2K | 5 | 0.8% |
| Gift | $2.7K | 41 | 0.7% |
| Education | $1.5K | 3 | 0.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $157,454.76 (40.4%) of $389,935.86 in this company's General Payments records across 66 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for DENTSPLY IH Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Mark Ludlow
$49,855.49 across 67 reported transactions
- 2
Barry Goldenberg
$33,700.26 across 49 reported transactions
- 3
Mark Montana
$29,425.99 across 68 reported transactions
- 4
Daniel Butterman
$24,922.01 across 60 reported transactions
- 5
Joseph Schmidt
$19,551.01 across 55 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as DENTSPLY IH Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about DENTSPLY IH Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with DENTSPLY IH Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Manual Surgical Sciences, LLC
Ecential Robotics
CurveBeam LLC
Novastep Inc.
Molnlycke Health Care US, LLC
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.